Publication | Closed Access

Edaravone dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke

InflammationAnti-inflammatoryEdaravone DexborneolMedicineImmunologyCell DeathNeuroprotective BenefitsBrain-immune InteractionPharmacotherapyNeurologyNeuroprotectionExperimental Ischemic StrokeCerebral Blood FlowPharmacologyNeuroimmunologyIschemic SyndromeNeuroinflammation